Cargando…
New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells
Topical treatments of localized neuropathic pain syndromes in general are mostly neglected, mainly due to the fact that most pain physicians expect that a topical formulation needs to result in a transdermal delivery of the active compounds. On the basis of the practical experience, this study bring...
Autores principales: | Keppel Hesselink, J M, Kopsky, D J, Sajben, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055105/ https://www.ncbi.nlm.nih.gov/pubmed/27757050 http://dx.doi.org/10.2147/JPR.S115407 |
Ejemplares similares
-
New models to study vulvodynia: hyperinnervation and nociceptor sensitization in the female genital tract
por: Barry, Christine M., et al.
Publicado: (2018) -
Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
por: Keppel Hesselink, Jan M, et al.
Publicado: (2019) -
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and
topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013) -
Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017) -
Emerging Evidence of Macrophage Contribution to Hyperinnervation and Nociceptor Sensitization in Vulvodynia
por: Barry, Christine Mary, et al.
Publicado: (2019)